Myomo Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
195
- Stock Symbol
-
MYO
- Investments
-
1
- Share Price
-
$1.23
- (As of Friday Closing)
Myomo General Information
Description
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Contact Information
Website
www.myomo.comCorporate Office
- 45 Blue Sky Drive
- Suite 101
- Burlington, MA 01803
- United States
Corporate Office
- 45 Blue Sky Drive
- Suite 101
- Burlington, MA 01803
- United States
Myomo Stock Performance
As of 13-Nov-2026, Myomo’s stock price is $1.23. Its current market cap is $49.3M with 40.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.23 | $1.21 | $0.60 - $1.89 | $49.3M | 40.1M | 391K | -$0.35 |
Myomo Financials Summary
As of 30-Sep-2026, Myomo has a trailing 12-month revenue of $45.5M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 68,416 | 34,720 | 210,613 | 122,435 |
| Revenue | 45,502 | 40,928 | 32,551 | 19,241 |
| EBITDA | (10,033) | (12,639) | (5,430) | (7,884) |
| Net Income | (15,077) | (15,574) | (6,184) | (8,148) |
| Total Assets | 33,805 | 38,637 | 42,244 | 14,582 |
| Total Debt | 21,407 | 19,382 | 8,106 | 601 |
Myomo Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Myomo Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Myomo Comparisons
Industry
Financing
Details
Myomo Competitors (6)
One of Myomo’s 6 competitors is Lifeward, a Formerly VC-backed company based in Yokneam Ilit, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lifeward | Formerly VC-backed | Yokneam Ilit, Israel | ||||
| Tyromotion | Private Equity-Backed | Graz, Austria | ||||
| Liberating Technologies | Corporate Backed or Acquired | Holliston, MA | ||||
| Rewalk | Venture Capital-Backed | Gimhae, South Korea | ||||
| Ekso Bionics Holdings | Formerly VC-backed | Richmond, CA |
Myomo Patents
Myomo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260130812-A1 | Orthotic device cuff assemblies | Pending | 08-Nov-2024 | ||
| WO-2026102128-A1 | Orthotic device cuff assemblies | Pending | 08-Nov-2024 | ||
| WO-2026102128-A4 | Orthotic device cuff assemblies | Pending | 08-Nov-2024 | ||
| US-20260130813-A1 | Orthotic device cuff systems | Pending | 08-Nov-2024 | ||
| WO-2026102130-A1 | Orthotic device cuff systems | Pending | 08-Nov-2024 | A61H1/0277 |
Myomo Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Myomo Investments (1)
Myomo’s most recent deal was a Joint Venture with Jiangxi Myomo Medical Assistive Appliance. The deal was made on 29-Dec-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jiangxi Myomo Medical Assistive Appliance | 29-Dec-2021 | Joint Venture | Therapeutic Devices |
Myomo ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
37.74 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Myomo FAQs
-
When was Myomo founded?
Myomo was founded in 2004.
-
Where is Myomo headquartered?
Myomo is headquartered in Burlington, MA.
-
What is the size of Myomo?
Myomo has 195 total employees.
-
What industry is Myomo in?
Myomo’s primary industry is Therapeutic Devices.
-
Is Myomo a private or public company?
Myomo is a Public company.
-
What is Myomo’s stock symbol?
The ticker symbol for Myomo is MYO.
-
What is the current stock price of Myomo?
As of 13-Nov-2026 the stock price of Myomo is $1.23.
-
What is the current market cap of Myomo?
The current market capitalization of Myomo is $49.3M.
-
What is Myomo’s current revenue?
The trailing twelve month revenue for Myomo is $45.5M.
-
Who are Myomo’s competitors?
Lifeward, Tyromotion, Liberating Technologies, Rewalk, and Ekso Bionics Holdings are some of the 6 competitors of Myomo.
-
What is Myomo’s annual earnings per share (EPS)?
Myomo’s EPS for 12 months was -$0.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
